Literature DB >> 31240315

Immunogenicity of Oral Polio Vaccine and Salk Inactive Polio Vaccine Against Xinjiang Imported Type 1 Wild Poliovirus.

Dongmei Yan1,2, Dongyan Wang1, Shuangli Zhu1, Yong Zhang1,3, Xiaolei Li1, Haishu Tang3, Jing Guan2, Wenbo Xu1,4.   

Abstract

BACKGROUND: An outbreak of an imported Type 1 wild poliovirus from Pakistan occurred in the Xinjiang Uygur Autonomous Region of China in 2011, although the local immunity status of the oral polio vaccine (OPV) was relatively satisfied.
METHODS: Neutralizing antibody titers against the Xinjiang strain and Sabin 1 strain were measured in 237 sera from 3 groups of fully OPV-vaccinated persons and 1 group of infants fully vaccinated with the inactive polio vaccine (IPV). Additionally, 17 sera collected from 1 Xinjiang poliomyelitis case and his 16 contacts were also tested. Genomic sequencing was conducted the Xinjiang strain.
RESULTS: The antibody titers against the Xinjiang strain in each of 237 sera were significantly lower than those against the Sabin 1 strain. Notably, 40.0% of children in Group 1 were seronegative against the Xinjiang strain, which indicated that they might play an important role in wild poliovirus transmission, although their antibody titers against the Sabin 1 strain varied between 1:8 and 1:512. Meanwhile, serological results of the Xinjiang poliomyelitis case and his contacts also provided evidence that a proportion of OPV-vaccinated children had indeed been involved in the transmission chain of the Xinjiang outbreak. Genomic sequencing indicated that the Xinjiang strain was greatly distinguishable from the Sabin 1 strain in neutralizing antigenic sites.
CONCLUSION: The lack of neutralizing antibodies against the Xinjiang strain in persons vaccinated by OPV may be associated with the transmission of Type 1 wild poliovirus in Xinjiang. Using Salk IPV along with OPV might be considered in a wild poliovirus outbreak response, especially in the countries which continued to have persistent wild poliovirus circulation.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Type 1 wild poliovirus; neutralizing antibody; oral polio vaccine

Year:  2020        PMID: 31240315     DOI: 10.1093/cid/ciz549

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  1 in total

1.  Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants.

Authors:  Ting Zhao; Zhaojun Mo; Zhifang Ying; Teng Huang; Yanchun Che; Guoliang Li; Xiaolei Yang; Mingbo Sun; Li Jiang; Li Shi; Hui Ye; Zhimei Zhao; Xiaochang Liu; Jing Li; Yanping Li; Rongcheng Li; Ruiju Jiang; Jianfeng Wang; Yuting Fu; Rufei Ma; Hongyuan Shi; Huan Yang; Changgui Li; Jingsi Yang; Qihan Li
Journal:  Ann Transl Med       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.